Scarica l'app Stockscreener
182.33
0.30%
0.44
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché BGNE Giù?
Forum
Previsione
Precedente Chiudi:
$181.89
Aprire:
$180.08
Volume 24 ore:
89,075
Relative Volume:
0.25
Capitalizzazione di mercato:
$19.33B
Reddito:
$3.32B
Utile/perdita netta:
$-860.46M
Rapporto P/E:
-10.92
EPS:
-16.6978
Flusso di cassa netto:
$-1.04B
1 W Prestazione:
+2.66%
1M Prestazione:
-15.15%
6M Prestazione:
+27.87%
1 anno Prestazione:
+1.15%
Intervallo 1D:
$179.73
$183.13
Intervallo di 1 settimana:
$177.09
$184.98
Portata 52W:
$126.97
$248.16
Beigene Ltd Adr Stock (BGNE) Company Profile
Nome
Beigene Ltd Adr
Settore
Industria
Telefono
13459494123
Indirizzo
C/O MOURANT GOVERNANCE SERVICES (CAYMAN), GRAND CAYMAN
Confronta BGNE con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BGNE
Beigene Ltd Adr
|
182.75 | 19.33B | 3.32B | -860.46M | -1.04B | -8.32 |
|
VRTX
Vertex Pharmaceuticals Inc
|
400.39 | 103.35B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
704.60 | 77.35B | 13.85B | 4.65B | 3.32B | 40.41 |
|
ARGX
Argen X Se Adr
|
624.65 | 37.04B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
235.24 | 30.14B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
111.38 | 26.97B | 3.30B | -501.07M | 1.03B | -2.1146 |
Beigene Ltd Adr Stock (BGNE) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-03 | Ripresa | Morgan Stanley | Overweight |
| 2024-09-18 | Iniziato | JMP Securities | Mkt Outperform |
| 2024-02-06 | Ripresa | JP Morgan | Overweight |
| 2023-09-12 | Iniziato | Macquarie | Outperform |
| 2023-08-17 | Iniziato | Jefferies | Buy |
| 2023-07-17 | Iniziato | Citigroup | Buy |
| 2023-06-30 | Downgrade | Bernstein | Outperform → Mkt Perform |
| 2023-01-12 | Iniziato | Daiwa Securities | Buy |
| 2022-10-13 | Aggiornamento | Guggenheim | Neutral → Buy |
| 2022-10-13 | Aggiornamento | SVB Leerink | Mkt Perform → Outperform |
| 2022-08-09 | Ripresa | JP Morgan | Overweight |
| 2022-03-17 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| 2022-02-07 | Iniziato | Deutsche Bank | Buy |
| 2021-10-12 | Iniziato | Bernstein | Outperform |
| 2021-10-06 | Aggiornamento | CLSA | Underperform → Buy |
| 2021-03-08 | Iniziato | China Renaissance | Buy |
| 2021-03-01 | Downgrade | CLSA | Outperform → Underperform |
| 2020-11-09 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2020-11-06 | Downgrade | Maxim Group | Buy → Hold |
| 2020-11-06 | Downgrade | Piper Sandler | Neutral → Underweight |
| 2020-07-10 | Downgrade | CLSA | Buy → Outperform |
| 2020-03-13 | Aggiornamento | Macquarie | Underperform → Neutral |
| 2020-02-18 | Ripresa | Goldman | Buy |
| 2020-01-17 | Aggiornamento | CLSA | Outperform → Buy |
| 2020-01-17 | Ripresa | Morgan Stanley | Overweight |
| 2019-12-16 | Downgrade | Guggenheim | Buy → Neutral |
| 2019-12-16 | Downgrade | Piper Jaffray | Overweight → Neutral |
| 2019-11-19 | Downgrade | UBS | Buy → Neutral |
| 2019-11-13 | Downgrade | CLSA | Buy → Outperform |
| 2019-11-04 | Reiterato | Maxim Group | Buy |
| 2019-06-04 | Iniziato | Bernstein | Outperform |
| 2019-05-10 | Aggiornamento | CLSA | Outperform → Buy |
| 2019-03-15 | Iniziato | BofA/Merrill | Buy |
| 2019-01-04 | Downgrade | CLSA | Buy → Outperform |
| 2018-11-21 | Iniziato | JP Morgan | Overweight |
| 2018-09-25 | Iniziato | Leerink Partners | Outperform |
| 2018-05-17 | Reiterato | Maxim Group | Buy |
Mostra tutto
Beigene Ltd Adr Borsa (BGNE) Ultime notizie
FDA approves BeiGene's TEVIMBRA for advanced gastric cancer treatment - Investing.com
Weekly Upgrades and Downgrades - InvestorPlace
BeiGene shares reiterate Buy rating on robust oncology pipeline - Investing.com India
Super Micro Computer, Adobe And Nucor Are Among Top Large Cap Losers Last Week (December 9-13): Are The Others In Your Portfolio? - Benzinga
Beigene directors sell shares worth $194.2 million - Investing.com
Beigene president Wu Xiaobin reports $120,894 sale of economic interest By Investing.com - Investing.com South Africa
Beigene president Wu Xiaobin reports $120,894 sale of economic interest - Investing.com
Beigene sees $3.57 billion stock sale by Hillhouse Investment By Investing.com - Investing.com South Africa
Beigene sees $274 million stock sale by Hillhouse Investment By Investing.com - Investing.com
AGFA Gevaert NV (AGFB.BR) Stock Price, News & Analyst Forecast - eToro
Morgan Stanley increases BeiGene stock target on drug prospects - Investing.com
10 High Growth Healthcare Stocks to Invest in Now - Insider Monkey
Beigene's Wang Xiaodong sells shares worth $9.19 million - Investing.com
BeiGene stock outlook positive as Bernstein lifts price target, keeps Market Perform - Investing.com
China ADRs have increased to the largest share since late 2021 – GS - MSN
BeiGene settles patent litigation, extends BRUKINSA exclusivity - Investing.com
10 Biggest Biotechnology Companies - Investopedia
BeiGene announces name change to BeOne Medicines Ltd. - Investing.com
BeiGene shares lift on raised price target to $260 from $254 - Investing.com
UBS Raises BeiGene (BGNE.US) TP to US$289.7 as 3Q Results Beat - AASTOCKS.com
BeiGene shares fall despite better-than-expected Q3 results - Investing.com
BeiGene announces passing of board member Donald Glazer - Investing.com
BEIGENE Senior Staff Reportedly Investigated, but Not Related to Firm Operations - AASTOCKS.com
Indaptus Therapeutics partners with BeiGene for cancer study - Investing.com India
BeiGene stock momentum builds on Brukinsa success, says JPMorgan's Fye - Investing.com
CMBI Eyes Opportunities in Innovative Medical Insurance, Prefers WuXi AppTec/ BeiGene/ INNOVENT BIO/ SKB BIO-B/ GIANT BIOGENE/ 3SBIO/ Mindray Bio-MedicalUS StocksGlobal News Content - AASTOCKS.com
Financial Fitness Check: Examining BeiGene Ltd ADR (BGNE)’s Key Ratios - The Dwinnex
The Potential Rise in the Price of BeiGene Ltd ADR (BGNE) following insiders activity - Knox Daily
Samsara Inc (IOT) may enjoy gains as insiders got busy in the recent days - Knox Daily
Monitoring Ginkgo Bioworks Holdings Inc (DNA) after recent insider movements - Knox Daily
Insider Sale Alert: PepsiCo Inc [PEP] – Is it Time to sell? - Knox Daily
VZIO (VIZIO Holding Corp) may reap gains as insiders became active recently - Knox Daily
Investing in Allegro Microsystems Inc. (ALGM) Is Getting More Attractive - Knox Daily
Investing in Alphatec Holdings Inc (ATEC): What You Must Know - Knox Daily
An Analysis of Mercury Systems Inc (MRCY)’s Potential Price Growth - Knox Daily
XPeng Inc. Sponsored ADR (XPEV) Beats Stock Market Upswing: What Investors Need to Know - Yahoo Finance
BeiGene CEO John Oyler sells shares worth over $3.75 million - Investing.com
Royal Caribbean Group [RCL] Shares Rise 5.26 % on Wednesday - Knox Daily
Selling Buzz: UL Solutions Inc [ULS] 10% Owner ULSE Inc. sells 3,000,000 shares of the company - Knox Daily
Director Cui Xiangmin acquire 277,895 shares of Nuvation Bio Inc [NUVB] - Knox Daily
Taking a look at what insiders are doing to gauge the BeiGene Ltd ADR (BGNE)’s direction - Knox Daily
Stock Performance Spotlight: BeiGene Ltd ADR (BGNE) Ends the Day at 240.40, Up by 2.11 - The Dwinnex
Beigene Ltd Adr Azioni (BGNE) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Beigene Ltd Adr Azioni (BGNE) insider trading
| Commercio interno | Relazione | Data | Transazione | Costo | #Azioni | Valore ($) | #Azioni Totale |
|---|---|---|---|---|---|---|---|
| Wang Xiaodong | Chair, Scientific Advisory Brd |
Dec 10 '24 |
Option Exercise |
6.50 |
41,760 |
271,440 |
41,760 |
| Wang Xiaodong | Chair, Scientific Advisory Brd |
Dec 10 '24 |
Sale |
186.90 |
41,760 |
7,805,106 |
0 |
| BAKER BROS. ADVISORS LP | Director |
Dec 09 '24 |
Sale |
187.27 |
1,037,017 |
194,200,043 |
791,493 |
0.79%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):